Skip to main content

Table 4 Breast Cancer Total Cumulative Charges by Initial Treatment at Diagnosis and Charge Type

From: Estimation of healthcare‐related charges in women with BRCA mutations and breast cancer

Health care charges ($US) Surgical Resection n=73 Adjuvant n=553 Neoadjuvant n=148 Adjuvant vs. Neoadjuvant
Mean (SD) Median (IQR) Mean (SD) Median (IQR) Mean (SD) Median (IQR) p-value
Breast Cancer related
Facilities/ Technical 23,472
(21,512)
19,840
(28,345)
27,486
(24,400)
22,456
(32,113)
35,877
(27,496)
33,984
(38,937)
0.00
Physician/ Professional 12,942
(10,770)
10,840
(12,678)
15,575
(13,091)
12,449
(17,812)
17,340
(12,663)
15,536
(16,820)
0.04
Pharmacy 19,702
(57,840)
993
(2,650)
37,000
(66,360)
8,531
(51,815)
64,705
(79,214)
43,009
(83,327)
<0.0001
Total Anticancer Treatment 11,491
(43,165)
0
(0)
21,564
(53,960)
2,241
(13,526)
40,941
(71,342)
4,556
(57,935)
0.00
 Clinical Trial 47
(196)
0
(0)
31
(215)
0
(0)
78
(297)
0
(0)
0.01
 Chemotherapy 3,604
(12,107)
0
(0)
7,204
(14,053)
1,759
(6,352)
7,376
(10,451)
3,905
(9,278)
0.01
 Hormonal Therapy 1,022
(5,843)
0
(0)
836
(5,814)
0
(0)
399
(2,711)
0
(0)
0.95
 Biologic Medicine 6,818
(36,636)
0
(0)
13,492
(46,279)
0
(0)
33,088
(66,386)
0
(40,885)
<0.0001
 Chemotherapy Administration 2
(15)
0
(0)
0
(4)
0
(0)
0
(0)
0
(0)
.
Other Medication(s) 8,210
(21,536)
993
(2,559)
15,436
(23,472)
2,530
(24,473)
23,764
(24,934)
12,018
(42,041)
<0.0001
  1. SD Standard deviation, IQR Interquartile range